Brief: Daxor Corp - New Data Validating Benefits Of Company's Bva-100 Diagnostic Blood Test
03/10/2022 14:35
Oct 3 (Reuters) - Daxor Corp DXR.O :
* DAXOR CORP - NEW DATA VALIDATING BENEFITS OF COMPANY'S
BVA-100
DIAGNOSTIC BLOOD TEST
Source text for Eikon: ID:nGNX2mJJ3m
Further company coverage: DXR.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Daxor
See all newsNASDAQ RESUMED AT 02:03 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:58 PM
Brief: Daxor Corp Reaffirms Focus On Blood Volume Analysis Technology
Brief: Daxor Corporation Submits 510(K) To FDA For Next-Generation Blood Volume Analyzer
Brief: Daxor Corporation Streamlines Regulatory Strategy For Groundbreaking Diagnostic Device